Skip to main content

Familial Differentiated Carcinoma of the Thyroid

  • Chapter
Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schlumberger M, Baudin E, Travagli JP (1998) Papillary and follicular cancers of the thyroid. Presse Med 27:1479–1481

    PubMed  Google Scholar 

  2. Sizemore GM. In: Becker KL (ed) Principles and practice of endocrinology and metabolism, 2nd edn. Lippincott, Philadelphia, pp 1555–1564

    Google Scholar 

  3. Wells SJ (1994) New approaches to the patient with medullary carcinoma of the thyroid gland. Thyroid Today XVII:1–9

    Google Scholar 

  4. Ledger G, Khosla S, Lindor NM, Thibideau SN, Gharib H (1995) Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med 122:118–124

    PubMed  Google Scholar 

  5. Bell B, Mazzaferri EL (1993) Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature. Dig Dis Sci 38:185–190

    Article  PubMed  Google Scholar 

  6. Bartsch DK et al. (2000) A RET double mutation in the germline of a kindred with FMTC. Exp Clin Endocrinol Diabetes 108:128–132

    PubMed  Google Scholar 

  7. Belli S et al. (2003) Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers. Medicina (B Aires) 63:41–45

    PubMed  Google Scholar 

  8. Marsh DJ, Mulligan LM, Eng C (1997) RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res 47:168–178

    PubMed  Google Scholar 

  9. Uchino S et al. (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897–902

    Article  PubMed  Google Scholar 

  10. Bevan S et al. (2001) A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86:3701–3704

    Article  PubMed  Google Scholar 

  11. Robinson D, Orr TG (1955) Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 70:923

    Google Scholar 

  12. Nemec J et al. (1975) Familial occurrence of differentiated (nonmedullary) thyroid cancer. Oncology 32:151–157

    PubMed  Google Scholar 

  13. Fischer DK et al. (1989) Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest 7:323–325

    PubMed  Google Scholar 

  14. Austoni M (1988) Thyroid papillary carcinoma in identical twins. Lancet 1:1115

    Google Scholar 

  15. Burgess J, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J, Hoffman L (1997) Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345–348

    PubMed  Google Scholar 

  16. Christensen S, Ljungberg O (1983) Familial occurrence of papillary thyroid carcinoma. Br J Surg 70:908–909

    Google Scholar 

  17. Ozaki O et al. (1988) Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg 12:565–571

    PubMed  Google Scholar 

  18. Goldbar D, Easton DF, Cannon Albright LA, Skolnick MH (1994) A systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:200–209

    PubMed  Google Scholar 

  19. Gorson D (1992) Familial papillary carcinoma of the thyroid. Thyroid 2:131–132

    PubMed  Google Scholar 

  20. Kraimps, JL, Canzian F, Jost C et al. (1999) Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery 126:1188–1194

    Article  PubMed  Google Scholar 

  21. Grossman R, Tu S-H, Duh Q-Y, Siperstein AE, Novosolov F, Clark OH (1995) Familial nonmedullary thyroid cancer. Arch Surg 130:892–899

    PubMed  Google Scholar 

  22. Hrafnkelsson J et al. (2001) Familial nonmedullary thyroid cancer in Iceland. J Med Genet 38:189–191

    PubMed  Google Scholar 

  23. Lote K, Andersen K, Nordal E, Brennhovd IO (1980) Familial occurrence of papillary thyroid carcinoma. Cancer 46:1291–1297

    PubMed  Google Scholar 

  24. Phade V, Lawrence WR, Max MH (1981) Familial papillary carcinoma of the thyroid. Arch Surg 116:836–837

    PubMed  Google Scholar 

  25. Stoffer S, Dyke DL van, Bach JV, Szpunar W, Weiss L (1986) Familial papillary carcinoma of the thyroid. Am J Med Genet 25:775–782

    Article  PubMed  Google Scholar 

  26. Szanto J, Gundy C, Toth K, Kasler M (1990) Coincidental papillary carcinoma of the thyroid in two sisters. Oncology 47:92–94

    PubMed  Google Scholar 

  27. Grossman RF et al. (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892–897; discussion 898–899

    PubMed  Google Scholar 

  28. Lupoli G et al. (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637–639

    Article  PubMed  Google Scholar 

  29. Kraimps JL, Bouin-Pineau M-H, Amati P, Mothes D, Boneau D, Marechaud R, Barbier J (1997) Familial papillary carcinoma of the thyroid. Surgery 121:715–718

    PubMed  Google Scholar 

  30. Takami H, Ozaki O, Ito K (1996) Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 131:676

    Google Scholar 

  31. De Groot L, Paloyan E (1973) Thyroid carcinoma and radiation: a Chicago endemic. JAMA 225:487–491

    PubMed  Google Scholar 

  32. Favus M, Schneider AB, Stachura ME et al. (1976) Thyroid cancer occurring as a late consequence of head-and-neck irradiation: evaluation of 1056 patients. N Engl J Med 294:1019–1025

    PubMed  Google Scholar 

  33. Maxon HR (1985) Radiation-induced thyroid disease. Med Clin North Am 69:1049–1061

    PubMed  Google Scholar 

  34. Ron E et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259–277

    PubMed  Google Scholar 

  35. Ron E (2003) Cancer risks from medical radiation. Health Phys 85:47–59

    PubMed  Google Scholar 

  36. Hancock SL, Cox R.S, McDougall I.R (1991) Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599–605

    PubMed  Google Scholar 

  37. Fisher C, Edmonds CJ (1980) Papillary carcinoma of the thyroid in two brothers after chest fluoroscopy in childhood. Br Med J 281:1600–1601

    PubMed  Google Scholar 

  38. Samaan N (1989) Papillary carcinoma of the thyroid: heredity or radiation induced? Cancer Invest 7:399–400

    PubMed  Google Scholar 

  39. Ron E et al. (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280:347–355

    Article  PubMed  Google Scholar 

  40. Kazakov VS, Demidchik EP, Astakhova LN (1992) Thyroid cancer after Chernobyl. Nature 359:21

    Article  Google Scholar 

  41. Williams D (2001) Lessons from Chernobyl. BMJ 323:643–644

    Article  PubMed  Google Scholar 

  42. Williams ED (2003) Chernobyl, 15 years later, correlation of clinical, epidemiological and molecular outcomes. Ann Endocrinol (Paris) 64:72

    Google Scholar 

  43. Zelicoff AP, Pezzullo JC (2002) Thyroid cancer 15 years after Chernobyl. Lancet 359:1946–1947; author reply 1947

    PubMed  Google Scholar 

  44. Zafra Anta MA et al. (2002) Health effects of the Chernobyl disaster. Fifteen years afterwards. An Esp Pediatr 56:324–333

    PubMed  Google Scholar 

  45. Horn-Ross P, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau AC, Krone M (2001) Iodine and thyroid cancer risk among women in a multiethnic population: The Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10:979–985

    PubMed  Google Scholar 

  46. Williams E, Doniach I, Bjarnason O, Michie W (1977) Thyroid cancer in an iodine rich area: a histopathological study. Cancer 39:215–222

    PubMed  Google Scholar 

  47. Williams ED (1995) Mechanisms and pathogenesis of thyroid cancer in animals and man. Mutat Res 333:123–129

    PubMed  Google Scholar 

  48. Pal T et al. (2001) Increased risk for nonmedullary thyroid cancer in the first-degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307–5312

    Article  PubMed  Google Scholar 

  49. Frich L, Glattre E, Akslen LA (2001) Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5,673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 10:113–117

    PubMed  Google Scholar 

  50. Charkes ND (1998) On the prevalence of familial nonmedullary thyroid cancer. Thyroid 8:857–858

    PubMed  Google Scholar 

  51. Houlston R, Stratton MR (1995) Genetics of nonmedullary thyroid cancer. Q J Med 88:685–693

    Google Scholar 

  52. Houlston R (1998) Genetic predisposition to nonmedullary thyroid cancer. Nucl Med Commun 19:911–913

    PubMed  Google Scholar 

  53. Malchoff CD, Malchoff DM (1999) Familial nonmedullary thyroid carcinoma. Semin Surg Oncol 16:16–18

    Article  PubMed  Google Scholar 

  54. Ron E, Kleinerman RA, Boice JD Jr et al. (1987) A population based case-control study of thyroid cancer. JNCI 79:1–12

    PubMed  Google Scholar 

  55. Gardner E (1951) A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 3:167–176

    PubMed  Google Scholar 

  56. Gardner E, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139–148

    PubMed  Google Scholar 

  57. Camiel M, Mule JE, Alexander LL, Benninghoff DL (1968) Association of thyroid carcinoma with Gardner's syndrome in siblings. N Engl J Med 278:1056–1058

    PubMed  Google Scholar 

  58. Harach H, Williams GT, Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma; a distinct type of follicular cell neoplasm. Histopathology 25:549–561

    PubMed  Google Scholar 

  59. Piffer S (1988) Gardner's syndrome and thyroid cancer — a case report and review of the literature. Acta Oncol 27:413–415

    PubMed  Google Scholar 

  60. Lee F, McKinnon MD (1981) Papillary thyroid carcinoma associated with polyposis coli. Am J Gastroenterol 76:138–140

    PubMed  Google Scholar 

  61. Plail R, Bussey HJR, Glazer R, Thomson JPS (1987) Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 74:377–380

    PubMed  Google Scholar 

  62. Reed M, Quayle AR, Harris SC, Talbot CH (1990) The association between thyroid neoplasia and intestinal polyps. Ann R Coll Surg Engl 72:257–359

    Google Scholar 

  63. Chen Y, Ott DJ, Wu WC, Gelfand DW (1987) Cowden's disease: a case report and literature review. Gastrointest Radiol 12:325–329

    Article  PubMed  Google Scholar 

  64. Michaels R, Shakir KA (1993) Association of multinodular goiter with breast cancer: Cowden's disease. J Endocrinol Invest 16:909–911

    PubMed  Google Scholar 

  65. Ohta S, Katsura T, Shimada M, Shima A, Chishiro H, Matsubara H (1996) Ataxia-telangiectasia with papillary carcinoma of the thyroid. Am J Ped Hem Oncol 8:255–268

    Google Scholar 

  66. Verneris M, McDougall IR, Becton D, Link MP (2001) Thyroid carcinoma after successful treatment of osteosarcoma: a report of 3 patients. J Pediatric Hem Oncol 23:312–315

    Article  Google Scholar 

  67. Galanti MR et al. (1997) Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75:451–456

    PubMed  Google Scholar 

  68. Fagin JA (1997) Familial nonmedullary thyroid carcinoma — the case for genetic susceptibility. J Clin Endocrinol Metab 82:342–344

    Article  PubMed  Google Scholar 

  69. Loh KC (1997) Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107–113

    PubMed  Google Scholar 

  70. Ron E et al. (1991) Familial nonmedullary thyroid cancer. Oncology 48:309–311

    PubMed  Google Scholar 

  71. Flannigan G, Clifford RP, Winslet M, Lawrence DAS, Fiddian RV (1983) Simultaneous presentation of papillary carcinoma of the thyroid in a father and son. Br J Surg 70:181–182

    PubMed  Google Scholar 

  72. Canzian F, Stark M, Corvi R, Lesueur F (1998) High and low penetrance genes predisposing to thyroid cancer (abstract). Thyroid 8:1211

    Google Scholar 

  73. Bignell GR et al. (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123–1130

    Article  PubMed  Google Scholar 

  74. Canzian F et al. (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743–1748

    Article  PubMed  Google Scholar 

  75. Lesueur F et al. (1999) Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157–2162

    Article  PubMed  Google Scholar 

  76. McKay J, Williamson J, Lesueur F, Stark M, Duffield A, Canzian F, Romeo G, Hoffman L (1999) At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family. Eur J Endocrinol 141:122–125

    Article  PubMed  Google Scholar 

  77. McKay JD et al. (2001) Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440–446

    Article  PubMed  Google Scholar 

  78. Cetani F, Tonacchera M, Pinchera A, Barsacchi R, Basolo G, Miccoli PM, Pacini F (1999) Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas. J Endocrinol Invest 22:273–278

    PubMed  Google Scholar 

  79. Curtis L, Wyllie AH, Shaw JJ et al. (1994) Evidence against the involvement of APC mutation in papillary thyroid carcinoma. Eur J Cancer 30A:984–989

    Article  PubMed  Google Scholar 

  80. Bongarzone I et al. (1996) Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 81:2006–2009

    Article  PubMed  Google Scholar 

  81. Bongarzone I et al. (1997) Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 42:252–259

    Article  PubMed  Google Scholar 

  82. Beimfohr C et al. (1999) NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident. Int J Cancer 80:842–847

    PubMed  Google Scholar 

  83. Jhiang S, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C (1996) Targeted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375–378

    Article  PubMed  Google Scholar 

  84. Valent ADG, Bernheim A (1997) Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC (NTRK3) to human chromosomes 1q22, 9q22, and 15q25 by fluorescence in situ hybridization. Eur J Hum Genet 5:102–104

    PubMed  Google Scholar 

  85. Trovato M, Fraggetta F, Viillari D, Batolo D, Mackey K, Trimarchi F, Benvenga S (1999) Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer. J Clin Endocrinol Metab 84:3235–3240

    Article  PubMed  Google Scholar 

  86. Zhang J, Nelson M, McIver B Hay I, Goellner JR, Grant CS, Eberhardt NL, Smith DI (1998) Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene 17:789–793

    Article  PubMed  Google Scholar 

  87. Yeh J, Marsh DJ, Zedenius J, Dwight T, Delbridge L, Robinson BG, Eng C (1999) Finestructure deletion mapping of 10q22–24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways. Genes Chromosomes Cancer 26:322–328

    Article  PubMed  Google Scholar 

  88. Dahia PL et al. (1997) Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710–4713

    PubMed  Google Scholar 

  89. Marsh D, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM Jr, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Rileyt-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461–1472

    Article  PubMed  Google Scholar 

  90. Halachmi N, HS, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D (1998) Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 23:239–243

    Article  PubMed  Google Scholar 

  91. Gardner RJ, KD, Edkins E, Walpole IR, Macrae FA, Nasioulas S, Scott WJ (1997) The clinical correlates of a 3'truncating mutation in the adenomatous polyposis coli gene. Gastroenterology 113:326–331

    PubMed  Google Scholar 

  92. Hizawa K, Iida M, Aoyagi K, Yao T, Fujishima M (1997) Thyroid neoplasia in familial adenomatous polyposis/Gardner's syndrome. J Gastroenterology 32:196–199

    Google Scholar 

  93. Perrier N, Heerden JA van, Goellner JR, Williams ED, Gharib H, Marchesa P, Church JM, Fazio VW, Larson DR (1998) Thyroid cancer in patients with familial adenomatous polyposis. World J Surg 22:738–742

    Google Scholar 

  94. Goretzki PE, GV, Dozenrath C, Witte J, Roeher HD (1996) A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer. Surgery 120:1081–1088

    PubMed  Google Scholar 

  95. Schulte K, Staudt s, Niederracher D, Finken-Eigen M, Kohrer K, Goretzki PE, Roher HD (1998) Rare loss of heterozygosity of the MTS1 and MTS 2 tumor suppressor genes in differentiated human thyroid cancer. Horm Metab Res 30:549–554

    PubMed  Google Scholar 

  96. Kwok C, McDougall IR (1995) Familial differentiated carcinoma of the thyroid: report of 5 families. Thyroid 5:395–397

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Carlisle, M., McDougall, I. (2005). Familial Differentiated Carcinoma of the Thyroid. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27845-1_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-27845-1_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22309-2

  • Online ISBN: 978-3-540-27845-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics